GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accent Microcell Ltd (NSE:ACCENTMIC) » Definitions » Change In Working Capital

Accent Microcell (NSE:ACCENTMIC) Change In Working Capital : ₹-249 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Accent Microcell Change In Working Capital?

Accent Microcell's change in working capital for the quarter that ended in Mar. 2024 was ₹-249 Mil.

Accent Microcell's change in working capital for the fiscal year that ended in Mar. 2024 was ₹-249 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Accent Microcell Change In Working Capital Historical Data

The historical data trend for Accent Microcell's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accent Microcell Change In Working Capital Chart

Accent Microcell Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Change In Working Capital
-29.43 21.92 -108.03 -248.69

Accent Microcell Semi-Annual Data
Mar21 Mar22 Mar23 Mar24
Change In Working Capital -29.43 21.92 -108.03 -248.69

Accent Microcell Change In Working Capital Calculation

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-249 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows Fiscal Years EndedJanuary 31,(Amounts in millions)
Cash flows from operating activities: 2014 2013 2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net (566) (614) (796)
Inventories (1,667) (2,759) (3,727)
Accounts payable 531 1,061 2,687
Accrued liabilities 103 271 (935)
Accrued income taxes (1,224) 981 994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accent Microcell Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Accent Microcell's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Accent Microcell Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accent Microcell Ltd (NSE:ACCENTMIC) » Definitions » Change In Working Capital
Comparable Companies
Traded in Other Exchanges
N/A
Address
Shyamal Cross Roads, Anandnagar Road, 314, Shangrilla Arcade, Satellite, Ahmedabad, GJ, IND, 380015
Website
https://www.accentmicrocell.com
Accent Microcell Ltd is engaged in the manufacturing business of pharmaceutical excipients including products like Microcrystalline Cellulose which is a term for refined wood pulp and is used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production; Croscarmellose Sodium used as a super disintegrant in pharmaceutical formulations; Magnesium Stearate; Cellulose Powder, and others. Its business segments are segregated based on the location of its manufacturing facilities and include Dahej (SEZ Unit) which generates maximum revenue, Pirana, Unit III, and Inter Unit Sales. Geographically, a majority of the company's revenue is derived through the export of its products to various countries.

Accent Microcell Headlines

No Headlines